Post-approval studies (Phase 4)Study completedNCT02653482
What this trial is testing
Dapagliflozin Effect on Symptoms and Biomarkers in Patients With Heart Failure
Who this might be right for
Chronic Heart Failure With Reduced Systolic Function
Saint Luke's Health System 263